Woodlands-based pharma co. to receive $260M in drug dispute settlement


The Woodlands-based Lexicon Pharmaceuticals Inc. (Nasdaq: LXRX) will receive $260 million in a settlement payment related to one of its drug candidates.

French pharmaceutical company Sanofi SA (Nasdaq: SNY) will pay Lexicon Pharmaceuticals $260 million under the terms of the settlement, according to a Sept. 10 press release. Some $208 million is payable upfront, with the remainder to be paid to Lexicon within 12 months, the company said.

In addition to the settlement payout, Lexicon announced…

Previous LyondellBasell prices $1.1B public note offering to repay debts
Next AG Healey refusing to join Purdue Pharma settlement

No Comment

Leave a reply

Your email address will not be published. Required fields are marked *